2.4.0.8 HtmlAndXml 102 234 1 false 47 0 false 5 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.cytosorbents.com/role/DocumentAndEntityInformation Document and Entity Information R1.xml true false R2.htm 002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cytosorbents.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS R2.xml false false R3.htm 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cytosorbents.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) R3.xml false false R4.htm 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS R4.xml false false R5.htm 005 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIENCY) Sheet http://www.cytosorbents.com/role/ConsolidatedStatementOfChangesInRedeemableConvertiblePreferredStockAndStockholdersEquityDeficiency CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIENCY) R5.xml false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS R6.xml false false R7.htm 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.cytosorbents.com/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) R7.xml false false R8.htm 101 - Disclosure - BASIS OF PRESENTATION Sheet http://www.cytosorbents.com/role/BasisOfPresentation BASIS OF PRESENTATION R8.xml false false R9.htm 102 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES R9.xml false false R10.htm 103 - Disclosure - CONVERTIBLE NOTES Notes http://www.cytosorbents.com/role/ConvertibleNotes CONVERTIBLE NOTES R10.xml false false R11.htm 104 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficit STOCKHOLDERS' EQUITY (DEFICIT) R11.xml false false R12.htm 105 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.cytosorbents.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES R12.xml false false R13.htm 106 - Disclosure - NET LOSS PER SHARE Sheet http://www.cytosorbents.com/role/NetLossPerShare NET LOSS PER SHARE R13.xml false false R14.htm 107 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cytosorbents.com/role/SubsequentEvents SUBSEQUENT EVENTS R14.xml false false R15.htm 202 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesPolicies PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) R15.xml false false R16.htm 304 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitTables STOCKHOLDERS' EQUITY (DEFICIT) (Tables) R16.xml false false R17.htm 40101 - Disclosure - BASIS OF PRESENTATION (Details) Sheet http://www.cytosorbents.com/role/BasisOfPresentationDetails BASIS OF PRESENTATION (Details) R17.xml false false R18.htm 40201 - Disclosure - PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.cytosorbents.com/role/PrincipalBusinessActivityAndSummaryOfSignificantAccountingPoliciesDetails PRINCIPAL BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) R18.xml false false R19.htm 40301 - Disclosure - CONVERTIBLE NOTES (Details) Notes http://www.cytosorbents.com/role/ConvertibleNotesDetails CONVERTIBLE NOTES (Details) R19.xml false false R20.htm 40401 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitNarrativeDetails STOCKHOLDERS' EQUITY (DEFICIT) (Narrative) (Details) R20.xml false false R21.htm 40402 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Stock Option Activity) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitSummaryOfStockOptionActivityDetails STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Stock Option Activity) (Details) R21.xml false false R22.htm 40403 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Status of Non-Vested Options) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitSummaryOfStatusOfNonvestedOptionsDetails STOCKHOLDERS' EQUITY (DEFICIT) (Summary of Status of Non-Vested Options) (Details) R22.xml false false R23.htm 40404 - Disclosure - STOCKHOLDERS' EQUITY (DEFICIT) (Warrants to Purchase Common Stock) (Details) Sheet http://www.cytosorbents.com/role/StockholdersEquityDeficitWarrantsToPurchaseCommonStockDetails STOCKHOLDERS' EQUITY (DEFICIT) (Warrants to Purchase Common Stock) (Details) R23.xml false false R24.htm 40501 - Disclosure - COMMITMENTS AND CONTINGENCIES (Narrative) (Details) Sheet http://www.cytosorbents.com/role/CommitmentsAndContingenciesNarrativeDetails COMMITMENTS AND CONTINGENCIES (Narrative) (Details) R24.xml false false R25.htm 40601 - Disclosure - NET LOSS PER SHARE (Details) Sheet http://www.cytosorbents.com/role/NetLossPerShareDetails NET LOSS PER SHARE (Details) R25.xml false false R26.htm 40701 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.cytosorbents.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) R26.xml false false All Reports Book All Reports Element us-gaap_ConversionOfStockSharesConverted1 had a mix of decimals attribute values: 0 2. Element us-gaap_EquityIssuancePerShareAmount had a mix of decimals attribute values: 2 3. Element us-gaap_SharesOutstanding had a mix of decimals attribute values: 0 2. Element us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities had a mix of decimals attribute values: 0 2. Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Jan. 21, 1997' Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Process Flow-Through: 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) ctso-20130630.xml ctso-20130630.xsd ctso-20130630_cal.xml ctso-20130630_def.xml ctso-20130630_lab.xml ctso-20130630_pre.xml true true